Laobaixing Pharmacy (603883) - Total Liabilities
Based on the latest financial reports, Laobaixing Pharmacy (603883) has total liabilities worth CN¥12.61 Billion CNY (≈ $1.85 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 603883 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Laobaixing Pharmacy - Total Liabilities Trend (2011–2025)
This chart illustrates how Laobaixing Pharmacy's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Laobaixing Pharmacy total assets.
Laobaixing Pharmacy Competitors by Total Liabilities
The table below lists competitors of Laobaixing Pharmacy ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
|
USA | $27.10 Million |
|
Sundaram Finance Holdings Limited
NSE:SUNDARMHLD
|
India | Rs6.44 Billion |
|
Bolsas y Mercados Argentinos SA
BA:BYMA
|
Argentina | AR$2.01 Trillion |
|
Longshine Technology Co Ltd
SHE:300682
|
China | CN¥2.34 Billion |
|
Hangzhou DPtech Technologies Co Ltd
SHE:300768
|
China | CN¥473.17 Million |
|
Playa Hotels & Resorts BV
F:PL0
|
Germany | €1.33 Billion |
|
Wuxi Shangji Automation Co Ltd
SHG:603185
|
China | CN¥15.15 Billion |
|
Hubei Jianghan New Materials Co. Ltd. A
SHG:603281
|
China | CN¥351.43 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Laobaixing Pharmacy's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Laobaixing Pharmacy to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Laobaixing Pharmacy's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Laobaixing Pharmacy (2011–2025)
The table below shows the annual total liabilities of Laobaixing Pharmacy from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥12.85 Billion ≈ $1.88 Billion |
-14.27% |
| 2024-12-31 | CN¥14.99 Billion ≈ $2.19 Billion |
+7.51% |
| 2023-12-31 | CN¥13.94 Billion ≈ $2.04 Billion |
-2.50% |
| 2022-12-31 | CN¥14.30 Billion ≈ $2.09 Billion |
+17.41% |
| 2021-12-31 | CN¥12.18 Billion ≈ $1.78 Billion |
+87.99% |
| 2020-12-31 | CN¥6.48 Billion ≈ $948.04 Million |
+7.09% |
| 2019-12-31 | CN¥6.05 Billion ≈ $885.24 Million |
+18.26% |
| 2018-12-31 | CN¥5.12 Billion ≈ $748.55 Million |
+42.18% |
| 2017-12-31 | CN¥3.60 Billion ≈ $526.47 Million |
+21.37% |
| 2016-12-31 | CN¥2.96 Billion ≈ $433.78 Million |
+96.50% |
| 2015-12-31 | CN¥1.51 Billion ≈ $220.75 Million |
+4.47% |
| 2014-12-31 | CN¥1.44 Billion ≈ $211.31 Million |
+14.31% |
| 2013-12-31 | CN¥1.26 Billion ≈ $184.85 Million |
+43.11% |
| 2012-12-31 | CN¥882.72 Million ≈ $129.17 Million |
-3.30% |
| 2011-12-31 | CN¥912.83 Million ≈ $133.58 Million |
-- |
About Laobaixing Pharmacy
LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more